Showing results (971-980 of 2,917) with videos related to
Sort By:
Pageof 292
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2020
Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategiesVibeke Norvang, Gina H Brinkmann, Kazuki Yoshida, et al.Arthritis & Rheumatology (Hoboken, N.J.)|February 11, 2020
Association of Visceral Adiposity With Pain but Not Structural OsteoarthritisShanshan Li, Ann V Schwartz, Michael P LaValley, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2020
Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic SclerosisVivek Nagaraja, Marco Matucci-Cerinic, Daniel E Furst, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 17, 2022
Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung DiseaseYan Ye, Xueliang Zhang, Teng Li, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 21, 2022
Early Increase of Circulating Transitional B Cells and Autoantibodies to Joint-Related Proteins in Patients With Metastatic Melanoma Developing Checkpoint Inhibitor-Induced Inflammatory ArthritisMariele Gatto, Sara Bjursten, Charlotte A Jonsson, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2014
Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritisJun Li, Hui-Chen Hsu, Yana Ding, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2014
Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritisNorman T Ilowite, Kristi Prather, Yuliya Lokhnygina, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathwayAdam P Cribbs, Alan Kennedy, Henry Penn, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trialMaxime Dougados, Désirée van der Heijde, Joachim Sieper, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Macrophage migration inhibitory factor down-regulates the RANKL-RANK signaling pathway by activating Lyn tyrosine kinase in mouse modelsSe Hwan Mun, Dongmyung Oh, Sun-Kyeong LeePageof 292